These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28749474)

  • 1. Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
    Caswell-Jin JL; Gupta T; Hall E; Petrovchich IM; Mills MA; Kingham KE; Koff R; Chun NM; Levonian P; Lebensohn AP; Ford JM; Kurian AW
    Genet Med; 2018 Feb; 20(2):234-239. PubMed ID: 28749474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
    Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
    Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
    JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
    Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
    J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
    Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
    JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NCCN Criterion "Young Age at Onset" Alone is Not an Indicator of Hereditary Breast Cancer in Iranian Population.
    Ebrahimi E; Sellars E; Shirkoohi R; Harirchi I; Ghiasvand R; Mohebbi E; Zendehdel K; Akbari MR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):763-770. PubMed ID: 31451522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
    Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
    Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
    LaDuca H; Stuenkel AJ; Dolinsky JS; Keiles S; Tandy S; Pesaran T; Chen E; Gau CL; Palmaer E; Shoaepour K; Shah D; Speare V; Gandomi S; Chao E
    Genet Med; 2014 Nov; 16(11):830-7. PubMed ID: 24763289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
    Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
    Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.
    Jones T; Trivedi MS; Jiang X; Silverman T; Underhill M; Chung WK; Kukafka R; Crew KD
    J Cancer Educ; 2021 Jun; 36(3):463-469. PubMed ID: 31802423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
    Horton C; Hoang L; Zimmermann H; Young C; Grzybowski J; Durda K; Vuong H; Burks D; Cass A; LaDuca H; Richardson ME; Harrison S; Chao EC; Karam R
    JAMA Oncol; 2024 Feb; 10(2):212-219. PubMed ID: 37924330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer.
    Feliubadaló L; Tonda R; Gausachs M; Trotta JR; Castellanos E; López-Doriga A; Teulé À; Tornero E; Del Valle J; Gel B; Gut M; Pineda M; González S; Menéndez M; Navarro M; Capellá G; Gut I; Serra E; Brunet J; Beltran S; Lázaro C
    Sci Rep; 2017 Jan; 7():37984. PubMed ID: 28050010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underrepresentation of racial and ethnic minorities in cascade testing for hereditary cancer syndromes.
    Ahsan MD; Webster EM; Nguyen NT; Qazi M; Levi SR; Diamond LC; Sharaf RN; Frey MK
    Eur J Hum Genet; 2023 Jul; 31(7):723-724. PubMed ID: 37117326
    [No Abstract]   [Full Text] [Related]  

  • 18. Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.
    Macklin S; Durand N; Atwal P; Hines S
    Genet Med; 2018 Mar; 20(3):346-350. PubMed ID: 29215655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Chang J; Seng S; Yoo J; Equivel P; Lum SS
    Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.